BIOMERICA INC FY 2026: Revenue $4.45M, EPS $(1.30) — 10-K SummaryTradingView·1 day ago, 09:05 PMBMRA+4.31%HSIC+2.80%
Biomerica FY26 net sales drop 16% to $4.45 million; dividend, interest and other income more than doubled to $1.23 millionPUBT·1 day ago, 09:02 PMBMRA+4.31%
BRC Group Holdings Secures Board Representation at Biomerica with 10.03% StakeTradingView·Aug 28 at 09:26 PMBMRA+4.31%RILYT-1.01%
Biomerica CEO Zackary S. Irani reports acquisition of $50,000 common sharesPUBT·Aug 27 at 09:24 PMBMRA+4.31%
Biomerica shares are trading higher after the company announced that it has entered into definitive agreements with institutional and individual investors for a private placement of 1,393,705 unregistered shares of the company’s common stock at a price of $1.60 per share.benzinga_article·Aug 27 at 03:56 PMBMRA+4.31%
Biomerica Enters Securities Purchase Agreement for Private Placement With InvestorsTradingView·Aug 26 at 09:03 PMBMRA+4.31%
Biomerica prices 1,393,705-share private placement at $1.6 per share, raising $2.23 millionPUBT·Aug 26 at 08:57 PMBMRA+4.31%RILYK0.00%
10:02 ETBiomerics Appoints Medical Device Industry Veteran Lokram Natarajan as Senior Vice President of Quality to Support Continued Global Growthprnewswire·Jul 28 at 02:02 PMBMRA+4.31%
Biomerica Lands a $1.75 Million CDMO Master Services Agreement for IVD Diagnostic Development | BMRA Stock NewsStockTitan·May 28 at 04:20 AMBMRA+4.31%LABU+0.58%
